Literature DB >> 23861298

Antimicrobial susceptibility of animal and human isolates of Clostridium difficile by broth microdilution.

Tina Pirš1, Jana Avberšek1, Irena Zdovc1, Brane Krt1, Alenka Andlovic2, Tatjana Lejko-Zupanc3, Maja Rupnik4,5,6, Matjaž Ocepek1.   

Abstract

A total of 188 human (n = 92) and animal (n = 96) isolates of Clostridium difficile of different PCR ribotypes were screened for susceptibility to 30 antimicrobials using broth microdilution. When comparing the prevalence of antimicrobial resistance, the isolates of animal origin were significantly more often resistant to oxacillin, gentamicin and trimethoprim/sulfamethoxazole (P<0.01). The most significant difference between the animal and human populations (P = 0.0006) was found in the level of imipenem resistance, with a prevalence of 53.3 % in isolates of human origin and 28.1 % in isolates of animal origin. Overall, the results show similar MICs for the majority of tested antimicrobials for isolates from human and animal sources, which were collected from the same geographical region and in the same time interval. This supports the hypothesis that C. difficile could be transmissible between human and animal hosts. Resistant isolates have been found in all animal species tested, including food and companion animals, and also among non-toxigenic isolates. The isolates of the most prevalent PCR ribotype 014/020 had low resistance rates for moxifloxacin, erythromycin, rifampicin and daptomycin, but a high resistance rate for imipenem. Multiresistant strains were found in animals and humans, belonging to PCR ribotypes 012, 017, 027, 045, 046, 078 and 150, and also to non-toxigenic strains of PCR ribotypes 010 and SLO 080.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23861298     DOI: 10.1099/jmm.0.058875-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

Review 1.  Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing.

Authors:  Zhong Peng; Dazhi Jin; Hyeun Bum Kim; Charles W Stratton; Bin Wu; Yi-Wei Tang; Xingmin Sun
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

2.  Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013.

Authors:  Isabella A Tickler; Richard V Goering; Joseph D Whitmore; Ashley N W Lynn; David H Persing; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

Review 3.  Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.

Authors:  Patrizia Spigaglia
Journal:  Ther Adv Infect Dis       Date:  2016-02

4.  Clostridioides difficile and multi-drug-resistant staphylococci in free-living rodents and marsupials in parks of Belo Horizonte, Brazil.

Authors:  Jordana Almeida Santana; Salene Angelini Colombo; Brendhal Almeida Silva; Amanda Nádia Diniz; Lara Ribeiro de Almeida; Carlos Augusto Oliveira Junior; Francisco Carlos Faria Lobato; Giliane de Souza Trindade; Adriano Pereira Paglia; Rodrigo Otávio Silveira Silva
Journal:  Braz J Microbiol       Date:  2021-11-11       Impact factor: 2.476

5.  Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011.

Authors:  C W Knetsch; T R Connor; A Mutreja; S M van Dorp; I M Sanders; H P Browne; D Harris; L Lipman; E C Keessen; J Corver; E J Kuijper; T D Lawley
Journal:  Euro Surveill       Date:  2014-11-13

6.  Highly Divergent Clostridium difficile Strains Isolated from the Environment.

Authors:  Sandra Janezic; Mojca Potocnik; Valerija Zidaric; Maja Rupnik
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

7.  Preliminary studies on isolates of Clostridium difficile from dogs and exotic pets.

Authors:  Sara Andrés-Lasheras; Inma Martín-Burriel; Raúl Carlos Mainar-Jaime; Mariano Morales; Ed Kuijper; José L Blanco; Manuel Chirino-Trejo; Rosa Bolea
Journal:  BMC Vet Res       Date:  2018-03-09       Impact factor: 2.741

Review 8.  Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.

Authors:  Saeed S Banawas
Journal:  Biomed Res Int       Date:  2018-02-21       Impact factor: 3.411

Review 9.  Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection.

Authors:  Simon D Baines; Mark H Wilcox
Journal:  Antibiotics (Basel)       Date:  2015-07-10

10.  CD2068 potentially mediates multidrug efflux in Clostridium difficile.

Authors:  Chawalit Ngernsombat; Suthasinee Sreesai; Phurt Harnvoravongchai; Surang Chankhamhaengdecha; Tavan Janvilisri
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.